Definity

About Lantheus Holdings

Lantheus Holdings is a pioneer in the radiopharmaceutical space, dedicated to transforming patient care through precision diagnostics and targeted radiotherapeutics. The company has achieved significant commercial success with its flagship product, PYLARIFY, a PSMA PET imaging agent for prostate cancer, and maintains a robust pipeline of next-generation diagnostic and therapeutic candidates. With a strong commercial infrastructure, deep manufacturing expertise, and strategic partnerships, Lantheus is strategically positioned to capitalize on the rapidly growing market for targeted radiopharmaceuticals in oncology and cardiology.

Therapeutic Areas